Changeflow GovPing Pharma & Drug Safety Phytogenic Composition for Animal Skeletal Musc...
Routine Guidance Added Final

Phytogenic Composition for Animal Skeletal Muscle Growth

Favicon for changeflow.com ChangeBridge: Patent Apps - Therapeutics (A61P)
Published March 26th, 2026
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application (US20260083805A1) detailing a phytogenic composition comprising Glycyrrhiza uralensis extract for promoting skeletal muscle growth in animals. This application outlines its use as a feed additive for agricultural applications.

What changed

This document is a published patent application from the USPTO, specifically application US20260083805A1, filed on September 20, 2024, and published on March 26, 2026. It describes a composition containing Glycyrrhiza uralensis extract or its active compounds, intended to promote skeletal muscle growth in animals and serve as a phytogenic feed additive.

While patent applications are not binding regulations, they indicate potential future product development and market trends in the agricultural and animal health sectors. Companies involved in animal feed additives, pharmaceuticals, and agricultural biotechnology should be aware of this disclosure as it may influence research and development in related areas. No immediate compliance actions are required, but it signals innovation in the use of plant-based extracts for animal growth promotion.

Source document (simplified)

← USPTO Patent Applications

COMPOSITION COMPRISING GLYCYRRHIZA URALENSIS EXTRACT AND METHOD AND USE THEREOF FOR SKELETAL MUSCLE GROWTH IN ANIMALS

Application US20260083805A1 Kind: A1 Mar 26, 2026

Inventors

Yu-Chuan LIANG, Bor-Rung OU

Abstract

The present disclosure provides a phytogenic-containing composition and applications thereof in agriculture. Specifically, the present disclosure relates to a composition comprising Glycyrrhiza uralensis extract, or an active compound isolated from the G. uralensis extract, a method for promoting skeletal muscle growth of animals by utilizing the composition, and use of the composition as a phytogenic feed additive for animals.

CPC Classifications

A61K 36/484 A61K 9/0053 A61K 31/352 A61P 21/00 G01N 33/5061

Filing Date

2024-09-20

Application No.

18891418

View original document →

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083805A1

Who this affects

Applies to
Drug manufacturers Food manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3114 Food & Beverage Manufacturing
Activity scope
Animal Feed Additives Drug Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Product Development
Topics
Agriculture Food Safety

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.